Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

GenSight’s LHON drug fails to meet endpoint in Phase III trial

pharmaceutical-technologyFebruary 19, 2019

Tag: GenSight , LHON drug , BCVA , GS010 drug

PharmaSources Customer Service